Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities
The long history of Cannabis sativa had its development stimulated and oriented for medicine after the discovery and chemical characterization of its main active ingredient, the 9-tetrahydrocannabinol (9-THC). Consequently, a binding site for 9-THC was identified in rat brains and the first cannabin...
Main Authors: | Pedro Cunha, Ana M Romão, Filipa Mascarenhas-Melo, Helena M Teixeira, Flávio Reis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha |
Similar Items
-
The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
by: Martina Rabino, et al.
Published: (2021-09-01) -
Phytocannabinoids, the Endocannabinoid System and Male Reproduction
by: Jinhwan Lim, et al.
Published: (2023-01-01) -
Chemism and the role of endocannabinoids in physiological processes
by: Prerad Ranka, et al.
Published: (2017-01-01) -
The endocannabinoid system and breathing
by: Beth M. Wiese, et al.
Published: (2023-04-01) -
The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)